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AbstrAct
Background: Renal disease is commonly encountered in patients with HIV infection. The estimated glomerular 
filtration rate (eGFR) provides a good assessment of the renal function and is widely used in screening populations 
that are at risk of renal dysfunction. We determined the prevalence of abnormal eGFR among HIV-positive children 
and factors associated with it.
Methods: In a cross-sectional study, children aged 15 years and below were recruited through systematic random 
sampling from the Paediatrics Infectious Disease Clinic of the University of Maiduguri Teaching Hospital until the 
desired sample size of 250 was reached. Clinical and laboratory information was obtained from the patient records 
and used for clinical staging and immunological classification. Serum creatinine was measured using Jaffe’s reaction 
and eGFR calculated using the Schwartz formula. The data obtained were analysed using SPSS version 16.
Results: A total of 157 (62.8%) children were on antiretroviral therapy (HAART) for periods ranging from 1 to 168 
months (mean duration 66.1 ± 46.5 months). Ninety-three (37.2%) children had advanced disease representing 
WHO clinical stages 3 and 4, whereas 103 (41.2%) had advanced or severe immunosuppression. The mean eGFR 
of the study population was 102 ± 41 mL/min/1.73 m2. Fifty-two children (20.1%) had low eGFR (<2 SD below the 
mean eGFR for age and sex) and 6 (2.4%) had high eGFR (>2 SD above the mean eGFR for age and sex). A total 
of 23 (9.2%) children had moderate to severe renal impairment, defined as eGFR <60 mL/min/1.73 m2. Age, sex, 
socio-economic status, mode of transmission as well as history of HAART usage were not significantly associated 
with abnormal eGFR. However, relatively shorter duration of treatment with HAART, as well as advanced clinical or 
immunological stage were all significantly associated with abnormal eGFR.   
Conclusion: Renal dysfunction is common among children with HIV disease in Maiduguri with over a third of those 
affected having moderate to severe renal dysfunction. Abnormal renal function is more frequent among children 
with advanced clinical and immunological disease. We recommend the regular determination of eGFR and early 
initiation of HAART in all children with HIV disease.
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INtrODUctION
The global HIV and AIDS scourge constitutes an impor-
tant public health issue, particularly in sub-Saharan 
Africa [1]. Nigeria harbours the largest number of HIV-
positive children in the world [2]. With continuously 
improving access to diagnosis, these children are increas-
ingly surviving into adolescence and adulthood. Thus, 
HIV infection in children now runs a chronic course with 
long-term multisystem complications such as renal and 
cardiac disease [3–5].
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The kidney is a primary target organ in HIV infection. 
Although the mechanism remains poorly understood, 
direct viral invasion and genetic factors are known to play 
significant roles [6–9]. A variety of renal disorders may 
occur through the course of HIV infection. These can be 
acute or chronic [10] and manifest through a spectrum of 
clinical syndromes including HIV-associated nephropathy 
(HIVAN), acute tubular dysfunction, fluid and electrolyte 
abnormalities or renal failure caused by infectious diseases 
and nephrotoxic drugs. Immune-mediated glomerulopathies 
(IgA, lupus-like syndromes) and HIV-associated thrombotic 
microangiopathies are not uncommon [10]. These disorders 
may lead to chronic kidney disease. In addition, several 
drugs used in the management of HIV infection and AIDS 
require dose adjustment or are contraindicated in the 
presence of declining renal function [11].  Consequently, 
routine screening and periodic evaluation for renal abnor-
malities have been generally accepted in the management 
of children living with HIV [11].
Glomerular filtration rate (GFR) remains the best test in 
assessing the level of kidney function and determining the 
stage of kidney disease. Estimated glomerular filtration rate 
(eGFR), calculated from the serum creatinine concentration, 
is widely used in lieu of measured GFR, due to the ease of 
its determination. The eGFR formulae are based on pre-
dicted 24-hour creatinine excretion rate, which is a function 
of the muscle mass. Hence, eGFR may be erroneously low 
or high in highly muscular and very lean individuals, respec-
tively [12]. eGFR has been shown to have a higher sensiti-
vity in detecting renal dysfunction among HIV-positive 
children when compared with other commonly used 
parameters like proteinuria [13,14]. 
Several studies have reported varying prevalence of abnor-
mal eGFR among HIV-positive children. Fredrick et al. [15] 
studied 240 children in Tanzania and found 65.4% of 
them with eGFR <90 mL/min/1.73 m2, 14 (5.8%) of whom 
had eGFR of 30–59 mL/min/1.73 m2. Low CD4 percent 
and lower CD4 counts were associated with higher pre-
valence of microalbuminuria and significant proteinuria. 
Dondo et al. [16] from Zimbabwe reported low eGFR 
(<90 mL/min/1.73 m2) in 34.6% with 2 children (1%) having 
eGFR of <60 mL/min/1.73 m2. Older children and those 
with WHO clinical stage 4 disease were more likely to 
have low eGFR. In another study, from Abuja, Nigeria, 
Okechukwu et al. [17] reported a prevalence of low eGFR 
among 26.7%, 2 (1.2%) of whom had eGFR of <60 mL/
min/1.73 m2. In a related study, Iduoriyekemwen et al. [18] 
reported low eGFR in 5.1% of the children they studied in 
Benin, Nigeria. None of these children with low eGFR had 
significant proteinuria or microalbuminuria. They also found 
advanced clinical stages (WHO clinical stages 3 and 4) to 
be associated with renal disease.
Although several African studies have reported on the 
prevalence of abnormal eGFR among HIV-infected children, 
most have focused on factors associated with proteinuria 
or macroalbuminuria. Abnormal eGFR may exist in the 
absence of other markers of renal disease [18]. We there-
fore conducted this study among HIV-positive children in 
our centre to determine the prevalence of abnormal eGFR 
and to identify any associated risk factors. 
MEtHODs
This cross-sectional, descriptive study was conducted 
between February and October 2014 at the Paediatric 
Infectious Disease Clinic of the University of Maiduguri 
Teaching Hospital, Borno State, located in the North-
Eastern region of Nigeria. The Infectious Disease Clinic has 
an average patient load of 50–60 patients per week. 
We recruited HIV-infected children (two positive DNA 
polymerase chain reaction tests for those aged <18 months 
and two positive antibody tests for older children) aged 15 
years and below. The minimum sample size was calculated 
at 250 participants using Taylor’s formula [19], with the 
prevalence of abnormal GFR estimated at 20.5% based on 
a previous study [20].
Participants were recruited by using simple balloting to 
select one child from the first four to register at the clinic 
for the day, and thereafter every fourth child. In the case of 
non-eligibility or unwillingness to participate, the very next 
eligible patient was selected. Children with sickle cell 
anaemia, hepatitis B infection or hepatitis C infection were 
excluded. Enrolment continued until the target of 250 
participants was reached.
The study was approved by the Research and Ethics 
Committee of UMTH. Informed consent was obtained 
from the parents or caregivers. The eGFR results were 
discussed with parents and caregivers and those children 
with abnormal results were referred to the nephrology unit 
for further evaluation.
study procedures
Demographic and clinical information, including anthro-
pometric measurements, were recorded using a structured 
data capture sheet. Weight and height were measured to 
the nearest 0.05 kg and 0.5 cm, respectively, using a 
Wunder stadiometer fitted with a calibrated weighing scale. 
The height was measured with the child standing erect and 
the head positioned such that the Frankfurt plane was 
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horizontal, feet together, knees straight and heels, buttocks, 
shoulder blade and occiput in contact with the vertical 
surface of the stadiometer. The height measurement was 
taken with the examiner’s eyes at the level of the headboard. 
For younger children or ill patients who could not stand 
erect, a measuring board was used with the help of an 
assistant. Socio-economic status of the children was deter-
mined from the parents’ educational level and occupation 
using Oyedeji’s model [21]. The clinical features and anthro-
pometry were used to stage the patients as per the WHO 
clinical staging for infants and children [22]. WHO clinical 
stages 1 and 2 were considered as non-advanced disease 
and stages 3 and 4 as advanced disease. Age categorization 
was based on the WHO immunological classification of 
HIV infection in children [22].
Venous blood samples in an ethylene diamine tetra-acetic 
acid (EDTA) bottle was used for measurement of the 
CD4+ count and CD4+%; blood in a lithium heparin bottle 
was used for creatinine estimation. All samples were 
analysed on the day of collection.   
Screening for hepatitis B surface antigen (HBsAg) and 
hepatitis C virus antibody (HCV Ab) was carried out using 
the HBsAg and HCV Ab Gold rapid screening test (Micro-
point Biotechnologies, China). Patients found to be posi-
tive for either HBsAg or HCV Ab were excluded from 
the study. 
The CD4+ count and CD4+% (for children <5 years) was 
obtained by using a PartecTM flow cytometer and CD4+ 
easy count kit (Go˝rlitz, Germany). Using the WHO age-
related CD4 count and CD4% values, the children were 
stratified into four groups: no significant immunosuppres-
sion, mild immunosuppression, advanced immunosuppres-
sion, and severe immunosuppression [22]. For the purpose 
of this study, the no significant and mild immunosuppression 
groups were combined as non-severe immunosuppression, 
whereas the advanced and severe suppression groups 
were combined as severe immunosuppression.
Serum creatinine level was estimated using a standard 
method based on Jaffe’s reaction [23] on a JenwayTM colori-
meter at the UMTH Chemical Pathology Laboratory by an 
experienced laboratory scientist. GFR was estimated using 
the Schwartz formula [12].  The ranges for normal eGFR (in 
mL/min/1.73 m2) were 96 ± 22 (for children <2 years), 133 
± 27 (for those aged 2–12 years), 140 ± 30 (for males 
aged 13–21 years) and 126 ± 26 (for females aged 13–21 
years) [24].  Values less than 2 SD below the mean for 
the age and sex were considered as corresponding to 
impaired renal function.
The data were analysed using SPSS version 16.0. Continuous 
variables were expressed as means + standard deviation 
(M ± SD), while categorical variables were summarised 
using frequencies. Student’s t-test was used to test dif-
ferences between means, and chi-squared and Fisher’s 
exact tests were used for categorical variables. A p value of 
<0.05 was considered significant. 
rEsULts
A total of 250 patients were recruited. Their socio-demo-
graphic characteristics are summarised in Table 1. The 
children were aged between 5 and 180 months (mean 89 
± 48 months) and 46.4% were male. Most were aged ≥60 
months and 55% were of lower social class. 
The treatment modalities, mode of HIV transmission and 
disease severity are shown in Table 2. A total of 157 
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table 1.  Socio-demographic characteristics of the  
study population.
Variables Frequency Percentage (%)
Age (months)
0–-12 18 7.2
13–59 69 27.6
>60 163 65.2
Sex  
Male 116 46.4
Female 134 53.6
Social class
Upper 40 16.0
Middle 73 29.2
Lower 137 54.8
table 2.  Medication use, modes of transmission, disease 
severity, and immunosuppression among the study population.
Variables Frequency Percentage (%)
Medication
On HAART 157 62.8
HAART naïve 93 37.2
Mode of transmission  
Vertical 231 92.4
Blood transfusion 5 2.0
Unknown 14 5.6
Disease severity
Non-advanced HIV disease 157 62.8
Advanced HIV disease 93 37.2
Immunosuppression
Non-severe 147 58.8
Severe 103 41.2
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(62.8%) children were on HAART for a period ranging 
from 1 to 168 months (mean duration 66 ± 46 months. Of 
those on HAART, 143 (91.1%) were on a regimen con-
sisting of zidovudine, lamivudine and nevirapine. The 
remaining 14 patients were on regimens including either 
abacavir or efavirenz in place of nevirapine. Twenty (8%) 
of the 250 subjects were on anti-TB treatment, and 6 of 
these were on HAART. The majority of the participants 
had acquired the infection through vertical transmission. 
The mode of transmission was uncertain in 14 patients, 
who were mostly adolescents. A total of 93 subjects 
(37.2%) had advanced disease; 103 (41.2%) were severely 
immunosuppressed. 
The mean eGFR of the study population was 102 ± 41 mL/
min/1.73 m2. A total of 192 (76.8%) had normal eGFR 
whereas 58 (23.2%) had abnormal eGFR. Of the 58 with 
abnormal eGFR, 52 (20.8% of the total) and 6 patients had 
low and high values, respectively. Twenty-three subjects 
(9.2%) had moderate to severe renal impairment as defined 
by eGFR < 60 mL/min/1.73 m2. 
Although higher frequencies of abnormal eGFR were 
observed in children >60 months, among males and in 
children of low socio-economic status, the differences were 
not statistically signif icant. Modes of transmission and 
history of HAART medication were also not associated 
with abnormal eGFR. However, HAART treatment of 
short duration, as well as advanced clinical or immunological 
stage were all associated with abnormal eGFR (p < 0.05).  
DIscUssION
The low eGFR rate of 1 in 5 children which we report 
emphasises the high burden of renal disease among this 
group of children. An even higher prevalence of low eGFR 
(43.4%) was reported by Ezeonwu et al. [25] from Enugu, 
Nigeria, among children of similar age. Moderate to severe 
renal impairment (eGFR < 60 mL/min/1.73 m2) was very 
common in this study, accounting for 44.2% of those with 
low eGFR. This is comparable with that reported by 
Esezobor et al. [26] from Lagos and Wools-Kaloustian et al. 
[27] from Kenya. 
The slightly higher prevalence reported by Dondo et al. [16] 
from Zimbabwe may be due to the difference in methods 
of estimating the GFR. The modified Counahan–Barratt 
formula was used in the Zimbabwean study whereas we 
used the Schwartz formula, which tends to overestimate 
the GFR [29]. 
In contrast, Iduoriyekemwen et al. [18] reported a sub- 
stantially lower prevalence of 5.1% from Benin, whereas 
Ezeonwu et al. [25] did not find any child with eGFR < 60 
mL/min/1.73 m2 in their study from Enugu. In both of these 
studies, most of the patients were on HAART (100% in 
the Iduorivekemwen study and 77.4% in that by Ezeonwu 
et al.). In our study, 37.2% of the participants were not on 
HAART. In addition, our participants were older, implying 
longer exposure to the damaging effect of the virus. 
Furthermore, while 37.2% of the children in our study had 
advanced disease, only 4.4% of the children studied by 
Ezeonwu et al. [25] had the same disease severity. 
The younger children in our study had a lower frequency of 
abnormal eGFR, although this trend was not statistically 
significant. Other studies have demonstrated associations 
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table 3.  Association between abnormal eGFR and various 
potential risk factors.
Glomerular  
filtration rate
Abnormal 
n (%)
Normal n 
(%) χ
2 p value
Age (months)
0–-12 2 (11.1) 16 (88.9) 1.64 0.440
13–59 16 (23.2) 53 (76.8)
>60 40 (24.5) 123 (75.5)
Sex  
Male 30 (25.9) 86 (74.1) 0.86 0.350
Female 28 (20.9) 106 (79.1)
Social class
Upper 14 (35.0)   26 (65.0) 8.39 0.015
Middle 9 (12.3)   64 (87.7)
Lower 35 (25.5) 102 (74.5)
Mode of transmission 
Vertical 53 (22.9) 178 (77.1) 0.26 0.876
Blood transfusion 1 (20.0)    4 (80.0)
Unknown 4 (28.6)  10 (71.4)
Medication
On HAART 33 (21.0) 124 (79.0) 1.13 0.288
HAART naïve 25(26.9)   68 (73.1)
Duration on HAART
<1 year 13 (43.3) 17 (66.7) 13.07 0.001
1–5 years 11 (22.0) 39 (78.0)
>5 years 9 (11.7) 68 (88.3)
Disease severity
Non-advanced 19 (12.1) 138 (87.9) 29.18 <0.001
Advanced 39 (41.9) 54 (58.1)
Immunosuppression
NSIS 24 (16.3) 123 (83.7) 9.46 0.002
SIS 34 (33.0) 69 (67.0)
NSIS, non-severe immunosuppression; SIS, severe immunosuppression;  
χ2, chi squared.
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between age and abnormal eGFR [16,25]. In our study 
there were very few children aged one year and below.
HAART naivety was associated with a higher prevalence of 
abnormal eGFR. This relationship was further highlighted 
by the inverse relationship between duration of HAART 
usage and prevalence of abnormal eGFR. The use of 
HAART may reduce the direct effect of HIV on the renal 
cells and maintain or improve renal function [30]. Similar to 
previous studies [16,26], advanced HIV disease and severe 
immunosuppression were associated with higher preva-
lence of abnormal eGFR. Abnormally high eGFR values 
were recorded in a few patients in our study. This may 
indicate hyperfiltration or may reflect poor nutritional 
status as low lean muscle mass affects serum creatinine 
concentrations and thus leads to over-estimation of GFR 
using the Schwartz formula [26]. 
Our study had some limitations. We were not able to 
measure urine protein excretion and it is possible that 
some children with normal eGFR could have had pro-
teinuria, an important marker of HIVAN and other types of 
renal disease. Also, we relied on eGFR as a marker of renal 
function and this has its limitations as mentioned above.
 
cONcLUsIONs 
Abnormal renal function, as detected by eGFR, is common 
among children with HIV disease in Maiduguri, with over a 
third of those affected having moderate to severe renal 
impairment. Abnormal eGFR is more frequent among 
children with advanced clinical or immunological disease, 
while prolonged treatment with HAART is associated with 
lower prevalence. We recommend routine, periodic 
calculation of eGFR and early initiation of HAART in all 
children with HIV disease.
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